In silico Study of the Proteins Involved in the Persistence of Brucella spp.

Q3 Pharmacology, Toxicology and Pharmaceutics
Parisa Asadollahi, Nourkhoda Sadeghifard, Hossein Kazemian, Iraj Pakzad, Behrooz Sadeghi Kalani
{"title":"<i>In silico</i> Study of the Proteins Involved in the Persistence of <i>Brucella</i> spp.","authors":"Parisa Asadollahi,&nbsp;Nourkhoda Sadeghifard,&nbsp;Hossein Kazemian,&nbsp;Iraj Pakzad,&nbsp;Behrooz Sadeghi Kalani","doi":"10.2174/1570163819666220805161821","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>One of the major problems with Brucella infections is its tendency to become chronic and recurrent, providing a hindrance to the management of this infection. It has been proposed that chronicity is greatly affected by a phenomenon called persistence in bacteria. Several mechanisms are involved in bacterial persistence, including the type II toxin-antitoxin system, the SOS and oxidative and stringent responses.</p><p><strong>Methods: </strong>In this in silico study, these persistence mechanisms in Brucella spp. were investigated.</p><p><strong>Results: </strong>The structure and the interactions between modules involved in these systems were designed, and novel peptides that can interfere with some of these important mechanisms were developed.</p><p><strong>Conclusion: </strong>Since peptide-based therapeutics are a new and evolving field due to their ease of production, we hope that peptides developed in this study, as well as the information about the structure and interactions of modules of persistence mechanisms, can further be used to design drugs against Brucella persister cells in the hope of restraining the chronic nature of Brucellosis.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"20 1","pages":"e050822207324"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug discovery technologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1570163819666220805161821","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Background: One of the major problems with Brucella infections is its tendency to become chronic and recurrent, providing a hindrance to the management of this infection. It has been proposed that chronicity is greatly affected by a phenomenon called persistence in bacteria. Several mechanisms are involved in bacterial persistence, including the type II toxin-antitoxin system, the SOS and oxidative and stringent responses.

Methods: In this in silico study, these persistence mechanisms in Brucella spp. were investigated.

Results: The structure and the interactions between modules involved in these systems were designed, and novel peptides that can interfere with some of these important mechanisms were developed.

Conclusion: Since peptide-based therapeutics are a new and evolving field due to their ease of production, we hope that peptides developed in this study, as well as the information about the structure and interactions of modules of persistence mechanisms, can further be used to design drugs against Brucella persister cells in the hope of restraining the chronic nature of Brucellosis.

参与布鲁氏菌持续性的蛋白质的计算机研究。
背景:布鲁氏菌感染的主要问题之一是其倾向于成为慢性和复发,提供了一个障碍,这种感染的管理。有人提出,慢性在很大程度上受到细菌中一种被称为持久性的现象的影响。细菌的持续存在涉及多种机制,包括II型毒素-抗毒素系统、SOS和氧化和严格反应。方法:通过计算机模拟研究,对布鲁氏菌的这些持久性机制进行了研究。结果:设计了这些系统中涉及的模块之间的结构和相互作用,并开发了能够干扰这些重要机制的新型肽。结论:基于多肽的治疗方法因其易于生产而成为一个新兴的发展领域,我们希望本研究中开发的多肽以及持续机制模块的结构和相互作用信息可以进一步用于设计针对布鲁氏菌持续细胞的药物,以期抑制布鲁氏菌病的慢性性质。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current drug discovery technologies
Current drug discovery technologies Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
CiteScore
3.70
自引率
0.00%
发文量
48
期刊介绍: Due to the plethora of new approaches being used in modern drug discovery by the pharmaceutical industry, Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery. The journal is the forum for publishing both original research papers and reviews describing novel approaches and cutting edge technologies used in all stages of drug discovery. The journal addresses the multidimensional challenges of drug discovery science including integration issues of the drug discovery process.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信